Skip to content
Study details
Enrolling now

Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms

The University of Texas Health Science Center at San Antonio
NCT IDNCT06801639ClinicalTrials.gov data as of Apr 2026
Target enrollment

24

Study length

about 3.5 years

Ages

60–85

Locations

1 site in TX

About this study

This trial is testing a home-based device that uses transcranial direct current stimulation (tDCS) to improve mood in people with Alzheimer's Disease. The researchers hope to learn if 30 minute sessions of tDCS can help improve feelings and emotions in individuals with Alzheimer's. It involves the use of an investigational device called a tDC stimulator, which has not yet been approved by the FDA for treating Alzheimer's Disease.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Use Sham tDCS
  • 2.Use Transcranial direct current stimulation (tDCS)
Primary goalGeneralized Anxiety Disorder-7 Scale (GAD-7)

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low7%
Logistics
High100%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Generalized Anxiety Disorder-7 Scale (GAD-7), Montreal Cognitive Assessment (MoCA)

Devices

therapeutic

Body systems

Neurology